{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:45:40Z","timestamp":1781509540852,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,17]]},"DOI":"10.7759\/cureus.62528","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T13:03:41Z","timestamp":1718629421000},"source":"Crossref","is-referenced-by-count":1,"title":["Sjogren's Antibodies and Neonatal Lupus: A Scoping Review"],"prefix":"10.7759","author":[{"given":"Deepika","family":"Nagliya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courteney","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L","family":"Demory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M","family":"Kesselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-93","article-title":"Novel aspects of Sj\u00f6gren's syndrome in 2012","volume":"11","author":"Tincani A","year":"2013","unstructured":"Tincani A, Andreoli L, Cavazzana I, et al.. Novel aspects of Sj\u00f6gren's syndrome in 2012. BMC Med. 2013, 11:93. 10.1186\/1741-7015-11-93","journal-title":"BMC Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1127417","article-title":"Pathogenesis and treatment of Sjogren's syndrome: review and update","volume":"14","author":"Zhan Q","year":"2023","unstructured":"Zhan Q, Zhang J, Lin Y, Chen W, Fan X, Zhang D. Pathogenesis and treatment of Sjogren's syndrome: review and update. Front Immunol. 2023, 14:1127417. 10.3389\/fimmu.2023.1127417","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2174\/1573397112666160714164149","article-title":"Update on pathogenesis of Sjogren's syndrome","volume":"13","author":"Sandhya P","year":"2017","unstructured":"Sandhya P, Kurien BT, Danda D, Scofield RH. Update on pathogenesis of Sjogren's syndrome. Curr Rheumatol Rev. 2017, 13:5-22. 10.2174\/1573397112666160714164149","journal-title":"Curr Rheumatol Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-009-8190-6","article-title":"Pregnancy outcomes in patients with autoimmune diseases and anti-Ro\/SSA antibodies","volume":"40","author":"Brucato A","year":"2011","unstructured":"Brucato A, Cimaz R, Caporali R, Ramoni V, Buyon J. Pregnancy outcomes in patients with autoimmune diseases and anti-Ro\/SSA antibodies. Clin Rev Allergy Immunol. 2011, 40:27-41. 10.1007\/s12016-009-8190-6","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2021.0353","article-title":"Pregnancy and autoimmune disease","volume":"119","author":"Merz WM","year":"2022","unstructured":"Merz WM, Fischer-Betz R, Hellwig K, Lamprecht G, Gembruch U. Pregnancy and autoimmune disease. Dtsch Arztebl Int. 2022, 119:145-56. 10.3238\/arztebl.m2021.0353","journal-title":"Dtsch Arztebl Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/16-047","article-title":"Sj\u00f6gren syndrome and pregnancy: a literature review","volume":"21","author":"Gupta S","year":"2017","unstructured":"Gupta S, Gupta N. Sj\u00f6gren syndrome and pregnancy: a literature review. Perm J. 2017, 21:16-47. 10.7812\/TPP\/16-047","journal-title":"Perm J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2022.100140","article-title":"A meta-analysis of the effect of Sj\u00f6gren's syndrome on adverse pregnancy outcomes","volume":"77","author":"Geng B","year":"2022","unstructured":"Geng B, Zhang K, Huang X, Chen Y. A meta-analysis of the effect of Sj\u00f6gren's syndrome on adverse pregnancy outcomes. Clinics (Sao Paulo). 2022, 77:100140. 10.1016\/j.clinsp.2022.100140","journal-title":"Clinics (Sao Paulo)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3323-9","article-title":"Association between primary Sj\u00f6gren's syndrome and pregnancy complications: a systematic review and meta-analysis","volume":"35","author":"Upala S","year":"2016","unstructured":"Upala S, Yong WC, Sanguankeo A. Association between primary Sj\u00f6gren's syndrome and pregnancy complications: a systematic review and meta-analysis. Clin Rheumatol. 2016, 35:1949-55. 10.1007\/s10067-016-3323-9","journal-title":"Clin Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-023-07259-3","article-title":"Impact of Sj\u00f6gren's syndrome on maternal and fetal outcomes following pregnancy: a systematic review and meta-analysis of studies published between years 2007-2022","volume":"309","author":"Yang Y","year":"2024","unstructured":"Yang Y, Huang XX, Huo RX, Lin JY. Impact of Sj\u00f6gren's syndrome on maternal and fetal outcomes following pregnancy: a systematic review and meta-analysis of studies published between years 2007-2022. Arch Gynecol Obstet. 2024, 309:1135-49. 10.1007\/s00404-023-07259-3","journal-title":"Arch Gynecol Obstet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2165\/00148581-200406020-00001","article-title":"Neonatal lupus: clinical features and management","volume":"6","author":"Lee LA","year":"2004","unstructured":"Lee LA. Neonatal lupus: clinical features and management. Paediatr Drugs. 2004, 6:71-8. 10.2165\/00148581-200406020-00001","journal-title":"Paediatr Drugs"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2012.07940.x","article-title":"Neonatal lupus erythematosus and its clinical variability","volume":"10","author":"Inzinger M","year":"2012","unstructured":"Inzinger M, Salmhofer W, Binder B. Neonatal lupus erythematosus and its clinical variability. J Dtsch Dermatol Ges. 2012, 10:407-11. 10.1111\/j.1610-0387.2012.07940.x","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/ar3787","article-title":"Congenital heart block: evidence for a pathogenic role of maternal autoantibodies","volume":"14","author":"Ambrosi A","year":"2012","unstructured":"Ambrosi A, Wahren-Herlenius M. Congenital heart block: evidence for a pathogenic role of maternal autoantibodies. Arthritis Res Ther. 2012, 14:208. 10.1186\/ar3787","journal-title":"Arthritis Res Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2010.02437.x","article-title":"Spectrum of cardiac involvement in neonatal lupus","volume":"72","author":"Hornberger LK","year":"2010","unstructured":"Hornberger LK, Al Rajaa N. Spectrum of cardiac involvement in neonatal lupus. Scand J Immunol. 2010, 72:189-97. 10.1111\/j.1365-3083.2010.02437.x","journal-title":"Scand J Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000024423","article-title":"Sj\u00f6gren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects","volume":"123","author":"Mavragani CP","year":"2000","unstructured":"Mavragani CP, Tzioufas AG, Moutsopoulos HM. Sj\u00f6gren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects. Int Arch Allergy Immunol. 2000, 123:46-57. 10.1159\/000024423","journal-title":"Int Arch Allergy Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179281","article-title":"An overview of neonatal lupus with anti-Ro characteristics","volume":"22","author":"Gryka-Marton M","year":"2021","unstructured":"Gryka-Marton M, Szukiewicz D, Teliga-Czajkowska J, Olesinska M. An overview of neonatal lupus with anti-Ro characteristics. Int J Mol Sci. 2021, 22:9281. 10.3390\/ijms22179281","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/BF02722656","article-title":"Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective","volume":"69","author":"Friedman DM","year":"2002","unstructured":"Friedman DM, Rupel A, Glickstein J, Buyon JP. Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective. Indian J Pediatr. 2002, 69:517-22. 10.1007\/BF02722656","journal-title":"Indian J Pediatr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(00)01048-2","article-title":"Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela","volume":"37","author":"Moak JP","year":"2001","unstructured":"Moak JP, Barron KS, Hougen TJ, et al.. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol. 2001, 37:238-42. 10.1016\/s0735-1097(00)01048-2","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/art.10638","article-title":"Long-term followup of children with neonatal lupus and their unaffected siblings","volume":"46","author":"Martin V","year":"2002","unstructured":"Martin V, Lee LA, Askanase AD, Katholi M, Buyon JP. Long-term followup of children with neonatal lupus and their unaffected siblings. Arthritis Rheum. 2002, 46:2377-83. 10.1002\/art.10638","journal-title":"Arthritis Rheum"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.045","article-title":"Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA\/Ro-positive mothers","volume":"76","author":"Izmirly P","year":"2020","unstructured":"Izmirly P, Kim M, Friedman DM, et al.. Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA\/Ro-positive mothers. J Am Coll Cardiol. 2020, 76:292-302. 10.1016\/j.jacc.2020.05.045","journal-title":"J Am Coll Cardiol"},{"key":"ref20","unstructured":"Stop Bloq. Study to prevent fetal heart block. (2023). Accessed: February 5, 2024: https:\/\/stopbloq.org\/about-the-study\/."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-007-0003-4","article-title":"Epidemiology, etiology, detection, and treatment of autoantibody-associated congenital heart block in neonatal lupus","volume":"9","author":"Friedman DM","year":"2007","unstructured":"Friedman DM, Rupel A, Buyon JP. Epidemiology, etiology, detection, and treatment of autoantibody-associated congenital heart block in neonatal lupus. Curr Rheumatol Rep. 2007, 9:101-8. 10.1007\/s11926-007-0003-4","journal-title":"Curr Rheumatol Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.13338","article-title":"Maternal steroid therapy for fetuses with second-degree immune-mediated congenital atrioventricular block: a systematic review and meta-analysis","volume":"97","author":"Ciardulli A","year":"2018","unstructured":"Ciardulli A, D'Antonio F, Magro-Malosso ER, Manzoli L, Anisman P, Saccone G, Berghella V. Maternal steroid therapy for fetuses with second-degree immune-mediated congenital atrioventricular block: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2018, 97:787-94. 10.1111\/aogs.13338","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref23","unstructured":"Neonatal lupus. epidemiology, pathogenesis, clinical manifestations, and diagnosis. (2024). Accessed: February 25, 2024: https:\/\/www.uptodate.com\/contents\/neonatal-lupus-epidemiology-pathogenesis-clinical-manifestations-and-diagnosis#H1."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/art.42733","article-title":"Prospective evaluation of high titer autoantibodies and fetal home monitoring in the detection of atrioventricular block among anti-SSA\/Ro pregnancies","volume":"76","author":"Buyon JP","year":"2024","unstructured":"Buyon JP, Masson M, Izmirly CG, et al.. Prospective evaluation of high titer autoantibodies and fetal home monitoring in the detection of atrioventricular block among anti-SSA\/Ro pregnancies. Arthritis Rheumatol. 2024, 76:411-20. 10.1002\/art.42733","journal-title":"Arthritis Rheumatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1515\/jpm-2020-0543","article-title":"Neonatal lupus erythematosus\u00a0- practical guidelines","volume":"49","author":"Derdulska JM","year":"2021","unstructured":"Derdulska JM, Rudnicka L, Szykut-Badaczewska A, Mehrholz D, Nowicki RJ, Bara\u0144ska-Rybak W, Wilkowska A. Neonatal lupus erythematosus\u00a0- practical guidelines. J Perinat Med. 2021, 49:529-38. 10.1515\/jpm-2020-0543","journal-title":"J Perinat Med"},{"key":"ref26","unstructured":"Neonatal lupus. management and outcomes. (2024). Accessed: February 28, 2024: https:\/\/www.uptodate.com\/contents\/neonatal-lupus-management-and-outcomes."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021580","article-title":"An overview of the dry eye disease in Sj\u00f6gren's syndrome using our current molecular understanding","volume":"24","author":"Wu KY","year":"2023","unstructured":"Wu KY, Kulbay M, Tanasescu C, Jiao B, Nguyen BH, Tran SD. An overview of the dry eye disease in Sj\u00f6gren's syndrome using our current molecular understanding. Int J Mol Sci. 2023, 24:1580. 10.3390\/ijms24021580","journal-title":"Int J Mol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/253062-sjogrens-antibodies-and-neonatal-lupus-a-scoping-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T13:03:47Z","timestamp":1718629427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/253062-sjogrens-antibodies-and-neonatal-lupus-a-scoping-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.62528","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,17]]}}}